Adhera Therapeutics Inc Watch

from 8-K 4 pages Autotelic Inc. (The “Lender”), Hereby Offers to Marina Biotech, Inc., a Delaware Corporation (The “Borrower”), an Unsecured Line of Credit (The “Line”) in an Amount Not to Exceed $500,000 (Such Amount, the “Maximum Amount”). the Proceeds of All Advances Under the Line Will Be Used for Current Operating Expenses of the Borrower. at the Request of Lender, the Borrower Shall Inform the Lender of the Intended Use of Proceeds of Any Advance Under the Line

from 8-K 5 pages Vuong Trieu (The “Lender”), Hereby Offers to Marina Biotech, Inc., a Delaware Corporation (The “Borrower”), an Unsecured Line of Credit (The “Line”) in an Amount Not to Exceed $540,000 (Such Amount, the “Maximum Amount”). the Proceeds of All Advances Under the Line Will Be Used for Current Operating Expenses of the Borrower, Including the Payment of the Premium for the Annual Continuation of the Borrower’s D&O Liability Insurance. at the Request of Lender, the Borrower Shall Inform the Lender of the Intended Use of Proceeds of Any Advance Under the Line

from 8-K 34 pages This Loan Agreement (This “Agreement”) Will Set Forth Certain Understandings Between Mdrna, Inc., a Delaware Corporation (The “Borrower”), and Cequent Pharmaceuticals, Inc., a Delaware Corporation (The “Lender”), With Respect to Term Loans (Hereinafter Defined) to Be Made by the Lender to the Borrower. in Consideration of the Mutual Promises Contained Herein and in the Other Documents Referred to Below, and for Other Good and Valuable Consideration, Receipt and Sufficiency of Which Are Hereby Acknowledged, the Borrower and the Lender Agree as Follows: I. Amounts and Terms

from DEFA14A 34 pages This Loan Agreement (This “Agreement”) Will Set Forth Certain Understandings Between Mdrna, Inc., a Delaware Corporation (The “Borrower”), and Cequent Pharmaceuticals, Inc., a Delaware Corporation (The “Lender”), With Respect to Term Loans (Hereinafter Defined) to Be Made by the Lender to the Borrower. in Consideration of the Mutual Promises Contained Herein and in the Other Documents Referred to Below, and for Other Good and Valuable Consideration, Receipt and Sufficiency of Which Are Hereby Acknowledged, the Borrower and the Lender Agree as Follows: I. Amounts and Terms

from 8-K 16 pages Common Stock Purchase Warrant Mdrna, Inc

from DEFA14A 16 pages Common Stock Purchase Warrant Mdrna, Inc

from 10-Q 41 pages Loan and Security Agreement